Opioid Induced Gait Variability

NCT03121547 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Opioid Induced Motor Disturbances

Interventions

DRUG: Tapentadol 50 mg Oral Tablet
DRUG: Tramadol Hydrochloride 100 mg Extended Release Oral Tablet
DRUG: Placebo Oral Tablet

Sponsor

Frederiksberg University Hospital